Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Nosocomial bloodstream infections (BSIs) are important causes of morbidity and mortality in the United States. METHODS: Data from a nationwide, concurrent surveillance study (Surveillance and Control of Pathogens of Epidemiological Importance [SCOPE]) were used to examine the secular trends in the epidemiology and microbiology of nosocomial BSIs. RESULTS: Our study detected 24,179 cases of nosocomial BSI in 49 US hospitals over a 7-year period from March 1995 through September 2002 (60 cases per 10,000 hospital admissions). Eighty-seven percent of BSIs were monomicrobial. Gram-positive organisms caused 65% of these BSIs, gram-negative organisms caused 25%, and fungi caused 9.5%. The crude mortality rate was 27%. The most-common organisms causing BSIs were coagulase-negative staphylococci (CoNS) (31% of isolates), Staphylococcus aureus (20%), enterococci (9%), and Candida species (9%). The mean interval between admission and infection was 13 days for infection with Escherichia coli, 16 days for S. aureus, 22 days for Candida species and Klebsiella species, 23 days for enterococci, and 26 days for Acinetobacter species. CoNS, Pseudomonas species, Enterobacter species, Serratia species, and Acinetobacter species were more likely to cause infections in patients in intensive care units (P<.001). In neutropenic patients, infections with Candida species, enterococci, and viridans group streptococci were significantly more common. The proportion of S. aureus isolates with methicillin resistance increased from 22% in 1995 to 57% in 2001 (P<.001, trend analysis). Vancomycin resistance was seen in 2% of Enterococcus faecalis isolates and in 60% of Enterococcus faecium isolates. CONCLUSION: In this study, one of the largest multicenter studies performed to date, we found that the proportion of nosocomial BSIs due to antibiotic-resistant organisms is increasing in US hospitals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the United States and elsewhere, Candida species are a leading cause of health care–associated bloodstream infections (3–5).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [4]
In the citing paper
“The incidence of nosocomial candidiasis has increased over the past few decades [28,29,30,31,32].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Candidaemia is the most common form of invasive candidiasis associated with an unacceptably high mortality rates in excess of 40% even with the introduction of newer antifungal agents [30,32,33].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Data from a US surveillance study found that over a 7year period Candida spp.accounted for 4.6 bloodstream infections per 10,000 admissions and 9% of all bloodstream infections [1], whereas the incidence may vary between centers.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
In the citing paper
“Among documented invasive fungal infections, candidemia and invasive candidiasis are encountered with increasing incidence in nosocomial settings [1].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 1×
“[30] showed that mortality rates doubled, from 30% to 60%, when inappropriate empirical antibiotic therapy was given to ICU patients with BSIs.”
BackgroundNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387 · cited 3×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundMethodSelf-citationDiekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundWeinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Barth Reller, L. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,228 · cited 1×
“Recent studies have shown that the proportion of contaminants is lower if 2 or more positive blood culture results (of samples drawn within a few hours of each other) were required for inclusion [9, 32, 33].”
BackgroundPittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Kreger, B. E., Craven, D. E., Carling, P. C., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90101-1 · Cited by 595 · cited 1×
“The crude rate mortality ranged from 12% in total hospital populations to 80% in ICU patients [6–10].”
BackgroundEmergence of Vancomycin Resistance in Coagulase-Negative Staphylococci
Schwalbe, R. S., Stapleton, J. T., & Gilligan, P. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161507 · Cited by 584 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundFridkin, S. K., Steward, C. D., Edwards, J. R., Pryor, E. R., McGowan, Jr., Archibald, L. K., Gaynes, R. P., & Tenover, F. C. (1999) · Clinical Infectious Diseases · doi:10.1086/520193 · Cited by 486
Antibiotic Resistance in the Intensive Care Unit
Kollef, M. H., & Fraser, V. J. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-4-200102200-00014 · Cited by 478
Weinstein, M. P., Murphy, J. R., Reller, L. B., & Lichtenstein, K. A. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.1.54 · Cited by 472 · cited 1×
“Recent studies have shown that the proportion of contaminants is lower if 2 or more positive blood culture results (of samples drawn within a few hours of each other) were required for inclusion [9, 32, 33].”
BackgroundHereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage
Marcus, J. N., Watson, P., Page, D. L., Narod, S. A., Lenoir, G. M., Tonin, P., Linder-Stephenson, L., Salerno, G., Conway, T. A., & Lynch, H. T. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960215)77:4<697::aid-cncr16>3.0.co;2-w · Cited by 454
DiGIOVINE, B., CHENOWETH, C., WATTS, C., & HIGGINS, M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9808145 · Cited by 449 · cited 1×
“In recent series of ICU patients, crude mortality rates ranged from 35%–53% [4, 11].”
BackgroundBryan, C. S., Reynolds, K. L., & Brenner, E. R. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.4.629 · Cited by 360 · cited 1×
“[7, 12, 13].”
Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00240-x · Cited by 331 · cited 1×
“[25–29].”
Self-citationPfaller, M. A., Jones, R. N., & Beach, M. (1999) · Clinical Infectious Diseases · doi:10.1086/598640 · Cited by 312
Pittet, D., Li, N., Woolson, R. F., & Wenzel, R. P. (1997) · Clinical Infectious Diseases · doi:10.1086/513640 · Cited by 296 · cited 1×
“in the United States [3].”
Self-citationCollin, B. A., Leather, H. L., Wingard, J. R., & Ramphal, R. (2001) · Clinical Infectious Diseases · doi:10.1086/322604 · Cited by 286 · cited 1×
“00 Recent studies reported the incidence of BSIs to be between 1% in intensive care unit (ICU) patients [4] and 36% in bone-marrow transplant recipients [5].”
BackgroundWisplinghoff, H., Edmond, M. B., Pfaller, M. A., Jones, R. N., Wenzel, R. P., & Seifert, H. (2000) · Clinical Infectious Diseases · doi:10.1086/314040 · Cited by 235 · cited 1×
“[25–29].”
Self-citation(2000) · American Journal of Infection Control · doi:10.1067/mic.2000.110544 · Cited by 221
Sahm, D. F., Marsilio, M. K., & Piazza, G. (1999) · Clinical Infectious Diseases · doi:10.1086/520195 · Cited by 213 · cited 1×
“There are several differences between this surveillance project and other networks that monitor a variety of infections and/ or countries [14–16, 31].”
BackgroundEnterococcal Bacteremia: Risk Factors for Vancomycin Resistance and Predictors of Mortality
Lautenbach, E., Bilker, W. B., & Brennan, P. J. (1999) · Infection Control & Hospital Epidemiology · doi:10.1086/501624 · Cited by 167 · cited 1×
“Several recent studies found neutropenia to be independently associated with vancomycin-resistant enterococcal (VRE) infection when comparing patients with vancomycin-resistant and patients with vancomycin-susceptible enterococcal BSIs [37, 38].”
BackgroundJones, R. N., Marshall, S. A., Pfaller, M. A., Wilke, W. W., Hollis, R. J., Erwin, M. E., Edmond, M. B., & Wenzel, R. P. (1997) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00115-6 · Cited by 153
Self-citationSmith, T. L., & Jarvis, W. R. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)80082-3 · Cited by 151
Gatell, J. M., Trilla, A., Latorre, X., Almela, M., Mensa, J., Moreno, A., Miró, J. M., Martínez, J. A., de Anta, M. T. J., Soriano, E., et al. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.1.203 · Cited by 150 · cited 1×
“The crude rate mortality ranged from 12% in total hospital populations to 80% in ICU patients [6–10].”
BackgroundCarratalà, J., Rosón, B., Fernández-Sevilla, A., Alcaide, F., & Gudiol, F. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.8.868 · Cited by 133
Diekema, D. J., Pfaller, M. A., & Jones, R. N. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00204-2 · Cited by 129
Wisplinghoff, H., Reinert, R. R., Cornely, O., & Seifert, H. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1876-1880.1999 · Cited by 97 · cited 4×
“These rates are in accordance with recent data from Germany [40] but are lower than rates in southern Europe [41].”
BackgroundResultInfluentialSelf-citationAssociation of secondary and polymicrobial nosocomial bloodstream infections with higher mortality
Pittet, D., Li, N., & Wenzel, R. P. (1993) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02000400 · Cited by 94 · cited 1×
“The crude rate mortality ranged from 12% in total hospital populations to 80% in ICU patients [6–10].”
BackgroundSelf-citationWarren, D. K., Zack, J. E., Elward, A. M., Cox, M. J., & Fraser, V. J. (2001) · Clinical Infectious Diseases · doi:10.1086/322483 · Cited by 93 · cited 2×
“00 Recent studies reported the incidence of BSIs to be between 1% in intensive care unit (ICU) patients [4] and 36% in bone-marrow transplant recipients [5].”
BackgroundKresken, M., Häfner, D., & the Study Group Bacterial Resistance of the Paul-Ehrlich-Society for Chemotherapy (1999) · Infection · doi:10.1007/bf02561661 · Cited by 75
Bhorade, S. M., CHRISTENSON, J., Pohlman, A. S., Arnow, P. M., & Hall, J. B. (1999) · CHEST Journal · doi:10.1378/chest.115.4.1085 · Cited by 61 · cited 1×
“Several recent studies found neutropenia to be independently associated with vancomycin-resistant enterococcal (VRE) infection when comparing patients with vancomycin-resistant and patients with vancomycin-susceptible enterococcal BSIs [37, 38].”
BackgroundProspective multicentric study of the etiology of 1051 bacteremic episodes in 782 cancer patients
Cancer), C. (.-B. S. C. O. I. D. I., Coullioud, D., der Auwera, P. V., Viot, M., & Lasset, C. (1993) · Supportive Care in Cancer · doi:10.1007/bf00326637 · Cited by 49
Pfaller, M. A., Jones, R. N., Marshall, S. A., Edmond, M. B., & Wenzel, R. P. (1997) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00159-4 · Cited by 47
Self-citationHeinemann, B., Wisplinghoff, H., Edmond, M. B., & Seifert, H. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2211-2213.2000 · Cited by 45 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundSelf-citationWisplinghoff, H., Seifert, H., Coimbra, M. V. D. S., Wenzel, R. P., & Edmond, M. B. (2001) · Clinical Infectious Diseases · doi:10.1086/322610 · Cited by 33 · cited 1×
“[25–29].”
Self-citationPositive predictive value of blood cultures growing coagulase-negative staphylococci
Peacock, S. J., Bowler, I. C. J. W., & Crook, D. W. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91254-1 · Cited by 30 · cited 1×
“Recent studies have shown that the proportion of contaminants is lower if 2 or more positive blood culture results (of samples drawn within a few hours of each other) were required for inclusion [9, 32, 33].”
BackgroundKrupova, I., Kaiserová, E., Foltínová, A., Kovacicova, G., Kisková, M., Krchnakova, A., Kunova, A., Trupl, J., West, D., & Krčméry, V. (1998) · Journal of Chemotherapy · doi:10.1179/joc.1998.10.3.236 · Cited by 23 · cited 2×
“to those in recent studies from the United States [15, 35] but”
ResultNew Group Tracks Hospitals' Drug-Resistant Bugs
Voelker, R. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530270017008 · Cited by 18
Group, Doern, G. V., Jones, R. N., Pfaller, M. A., Erwin, M. E., & Ramirez-Rhonda, C. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00160-0 · Cited by 15
Research works printed but not linked: 1
- 1996, 77, 791, 10.1002/(SICI)1097-0142(19960215)77:4<791::AID-CNCR27>3.0.CO;2-V · DOI · Paper page
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
“Consistently identified as the third most frequent cause of nosocomial bloodstream infection (BSI) in the United States, enterococcal BSIs remain a significant problem [48, 49].”
BackgroundGuidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
“Gram negative bacilli accounted for 19% and 21% of CLABSIs reported to CDC(209) and the Surveillance and Control of Pathogens of Epidemiological Importance (SCOPE) database, respectively.(208) For all common pathogens causing CLABSIs, antimicrobial resistance is a problem, particularly in ICUs.”
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
“Indeed, Candida species are the fourth most common cause of nosocomial (hospital-acquired) bloodstream infections ( 13 ), and advanced medical procedures — such as the use of catheters, neonatal intensive care, major gut surgery, or liver transplantation — are predisposing factors to disseminated…”
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
“world for more than a decade [5–12].”
BackgroundInfluential
Metadata
- Authors
- Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B.
- Affiliations
- University of Cologne (DE)
- Virginia Commonwealth University (US)
- Corresponding author
- Edmond, M. B.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08-01
- Volume
- 39
- Issue
- 3
- Pages
- 309-317
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2171155970
- Cited by
- 4,496
- References
- 42
- Citations by year
- 2026: 78 · 2025: 138 · 2024: 137 · 2023: 171 · 2022: 209 · 2021: 187 · 2020: 229 · 2019: 252 · 2018: 215 · 2017: 238 · 2016: 255 · 2015: 271 · 2014: 291 · 2013: 257 · 2012: 241
- FWCI
- 105.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- nosocomial bloodstream infection, nosocomial infections, antibiotic resistance, methicillin-resistant Staphylococcus aureus, vancomycin resistance, Enterococcus faecium, Enterococcus faecalis, coagulase-negative staphylococci, candidiasis, intensive care unit, neutropenic patients, infectious disease epidemiology, temporal trends
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Candidiasis, Child, Child, Preschool, Cross Infection, Drug Resistance, Microbial, Female, Humans, Infant, Male, Middle Aged, Population Surveillance, Prospective Studies, Staphylococcal Infections, United States, Causality, Incidence, Fungemia, Bacteremia, Gram-Negative Bacterial Infections, Gram-Positive Bacterial Infections, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.